BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 27018342)

  • 21. ACE2 and Ang-(1-7) protect endothelial cell function and prevent early atherosclerosis by inhibiting inflammatory response.
    Zhang YH; Zhang YH; Dong XF; Hao QQ; Zhou XM; Yu QT; Li SY; Chen X; Tengbeh AF; Dong B; Zhang Y
    Inflamm Res; 2015 Apr; 64(3-4):253-60. PubMed ID: 25721616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of angiotensin-converting enzyme 2 and angiotensin(1-7) in 17beta-oestradiol regulation of renal pathology in renal wrap hypertension in rats.
    Ji H; Menini S; Zheng W; Pesce C; Wu X; Sandberg K
    Exp Physiol; 2008 May; 93(5):648-57. PubMed ID: 18296494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual deficiency of angiotensin-converting enzyme-2 and Mas receptor enhances angiotensin II-induced hypertension and hypertensive nephropathy.
    Ni J; Yang F; Huang XR; Meng J; Chen J; Bader M; Penninger JM; Fung E; Yu XQ; Lan HY
    J Cell Mol Med; 2020 Nov; 24(22):13093-13103. PubMed ID: 32971570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse.
    Thomas MC; Pickering RJ; Tsorotes D; Koitka A; Sheehy K; Bernardi S; Toffoli B; Nguyen-Huu TP; Head GA; Fu Y; Chin-Dusting J; Cooper ME; Tikellis C
    Circ Res; 2010 Oct; 107(7):888-97. PubMed ID: 20671240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of angiotensin-converting enzyme (ACE and ACE2) imbalance on tourniquet-induced remote kidney injury in a mouse hindlimb ischemia-reperfusion model.
    Yang XH; Wang YH; Wang JJ; Liu YC; Deng W; Qin C; Gao JL; Zhang LY
    Peptides; 2012 Jul; 36(1):60-70. PubMed ID: 22580272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin-converting enzyme 2-independent action of presumed angiotensin-converting enzyme 2 activators: studies in vivo, ex vivo, and in vitro.
    Haber PK; Ye M; Wysocki J; Maier C; Haque SK; Batlle D
    Hypertension; 2014 Apr; 63(4):774-82. PubMed ID: 24446061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin-converting enzyme 2 deficiency in whole body or bone marrow-derived cells increases atherosclerosis in low-density lipoprotein receptor-/- mice.
    Thatcher SE; Zhang X; Howatt DA; Lu H; Gurley SB; Daugherty A; Cassis LA
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):758-65. PubMed ID: 21252069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of catalase prevents hypertension and tubulointerstitial fibrosis and normalization of renal angiotensin-converting enzyme-2 expression in Akita mice.
    Shi Y; Lo CS; Chenier I; Maachi H; Filep JG; Ingelfinger JR; Zhang SL; Chan JS
    Am J Physiol Renal Physiol; 2013 Jun; 304(11):F1335-46. PubMed ID: 23552863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1-7 in experimental heart failure in angiotensin-converting enzyme 2-null mice.
    Patel VB; Bodiga S; Fan D; Das SK; Wang Z; Wang W; Basu R; Zhong J; Kassiri Z; Oudit GY
    Hypertension; 2012 Jun; 59(6):1195-203. PubMed ID: 22508831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin-(1-7) modulates renal vascular resistance through inhibition of p38 mitogen-activated protein kinase in apolipoprotein E-deficient mice.
    Potthoff SA; Fähling M; Clasen T; Mende S; Ishak B; Suvorava T; Stamer S; Thieme M; Sivritas SH; Kojda G; Patzak A; Rump LC; Stegbauer J
    Hypertension; 2014 Feb; 63(2):265-72. PubMed ID: 24191281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.
    Sahara M; Ikutomi M; Morita T; Minami Y; Nakajima T; Hirata Y; Nagai R; Sata M
    Cardiovasc Res; 2014 Feb; 101(2):236-46. PubMed ID: 24193738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of prolyl carboxypeptidase as an alternative enzyme for processing of renal angiotensin II using mass spectrometry.
    Grobe N; Weir NM; Leiva O; Ong FS; Bernstein KE; Schmaier AH; Morris M; Elased KM
    Am J Physiol Cell Physiol; 2013 May; 304(10):C945-53. PubMed ID: 23392115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis.
    Simões E Silva AC; Teixeira MM
    Pharmacol Res; 2016 May; 107():154-162. PubMed ID: 26995300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ACE2 deficiency enhances angiotensin II-mediated aortic profilin-1 expression, inflammation and peroxynitrite production.
    Jin HY; Song B; Oudit GY; Davidge ST; Yu HM; Jiang YY; Gao PJ; Zhu DL; Ning G; Kassiri Z; Penninger JM; Zhong JC
    PLoS One; 2012; 7(6):e38502. PubMed ID: 22693641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autocrine and paracrine function of Angiotensin 1-7 in tissue repair during hypertension.
    Meng W; Zhao W; Zhao T; Liu C; Chen Y; Liu H; Sun Y
    Am J Hypertens; 2014 Jun; 27(6):775-82. PubMed ID: 24429674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin type 2 receptor null mice express reduced levels of renal angiotensin II type 2 receptor/angiotensin (1-7)/Mas receptor and exhibit greater high-fat diet-induced kidney injury.
    Ali Q; Dhande I; Samuel P; Hussain T
    J Renin Angiotensin Aldosterone Syst; 2016 Jul; 17(3):. PubMed ID: 27496559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced angiotensin-converting enzyme 2 attenuates angiotensin II-induced collagen production via AT1 receptor-phosphoinositide 3-kinase-Akt pathway.
    Bu L; Qu S; Gao X; Zou JJ; Tang W; Sun LL; Liu ZM
    Endocrine; 2011 Apr; 39(2):139-47. PubMed ID: 21188549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MAS receptors mediate vasoprotective and atheroprotective effects of candesartan upon the recovery of vascular angiotensin-converting enzyme 2-angiotensin-(1-7)-MAS axis functionality.
    Pernomian L; do Prado AF; Gomes MS; Pernomian L; da Silva CHTP; Gerlach RF; de Oliveira AM
    Eur J Pharmacol; 2015 Oct; 764():173-188. PubMed ID: 26144375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin-converting enzyme 2 attenuates oxidative stress and VSMC proliferation via the JAK2/STAT3/SOCS3 and profilin-1/MAPK signaling pathways.
    Song B; Jin H; Yu X; Zhang Z; Yu H; Ye J; Xu Y; Zhou T; Oudit GY; Ye JY; Chen C; Gao P; Zhu D; Penninger JM; Zhong JC
    Regul Pept; 2013 Aug; 185():44-51. PubMed ID: 23816468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct roles for angiotensin-converting enzyme 2 and carboxypeptidase A in the processing of angiotensins within the murine heart.
    Garabelli PJ; Modrall JG; Penninger JM; Ferrario CM; Chappell MC
    Exp Physiol; 2008 May; 93(5):613-21. PubMed ID: 18356559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.